Lipe & Dalton purchased a new stake in The Clorox Company (NYSE:CLX – Free Report) during the second quarter, HoldingsChannel reports. The institutional investor purchased 5,925 shares of the company’s stock, valued at approximately $565,000.
A number of other hedge funds have also modified their holdings of the company. Darwin Wealth Management LLC acquired a new stake in Clorox in the 2nd quarter valued at approximately $29,000. Caitlin John LLC boosted its position in Clorox by 1,807.1% during the 4th quarter. Caitlin John LLC now owns 267 shares of the company’s stock worth $27,000 after acquiring an additional 253 shares during the last quarter. Ancora Advisors LLC acquired a new position in Clorox during the 2nd quarter worth approximately $28,000. Avalon Trust Co bought a new position in shares of Clorox during the 2nd quarter worth approximately $29,000. Finally, Markowski Investments acquired a new stake in shares of Clorox in the second quarter valued at approximately $30,000. 78.53% of the stock is currently owned by institutional investors.
Clorox Stock Down 1.5%
CLX traded down $1.37 during trading on Tuesday, reaching $91.69. 2,754,307 shares of the stock were exchanged, compared to its average volume of 2,597,211. The company has a debt-to-equity ratio of 15.80, a quick ratio of 0.38 and a current ratio of 0.66. The stock’s 50 day moving average price is $99.81 and its two-hundred day moving average price is $101.34. The Clorox Company has a twelve month low of $84.70 and a twelve month high of $128.90. The stock has a market cap of $11.09 billion, a P/E ratio of 19.02, a price-to-earnings-growth ratio of 2.91 and a beta of 0.56.
Clorox Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, August 28th. Shareholders of record on Wednesday, August 12th were given a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a yield of 5.5%. This is a boost from Clorox’s previous quarterly dividend of $1.24. The ex-dividend date of this dividend was Wednesday, August 12th. Clorox’s dividend payout ratio (DPR) is presently 103.73%.
Analyst Upgrades and Downgrades
CLX has been the topic of a number of research reports. JPMorgan Chase & Co. boosted their price objective on shares of Clorox from $92.00 to $95.00 and gave the stock an “underweight” rating in a research report on Tuesday, August 4th. Zacks Research lowered shares of Clorox from a “hold” rating to a “strong sell” rating in a research note on Tuesday, May 12th. Evercore set a $99.00 price target on shares of Clorox in a research report on Tuesday, August 4th. Weiss Ratings restated a “hold (c-)” rating on shares of Clorox in a research note on Friday, July 10th. Finally, UBS Group lifted their target price on Clorox from $100.00 to $105.00 and gave the company a “neutral” rating in a research report on Tuesday, August 4th. Twelve analysts have rated the stock with a Hold rating and five have issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Reduce” and an average price target of $102.40.
Check Out Our Latest Stock Report on Clorox
About Clorox
The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.
Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.
Recommended Stories
- Five stocks we like better than Clorox
- Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected
- Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock
- Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement
- Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
